DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has received a consensus rating of "Hold" from the thirteen brokerages that are covering the firm, Marketbeat.com reports. Eleven analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $18.6364.
Several equities analysts recently commented on XRAY shares. Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. UBS Group cut their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Finally, Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th.
Check Out Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
Shares of XRAY traded down $0.26 during trading hours on Wednesday, reaching $13.16. 6,019,803 shares of the company traded hands, compared to its average volume of 2,626,561. The stock's fifty day moving average is $14.44 and its 200 day moving average is $14.93. The stock has a market cap of $2.63 billion, a P/E ratio of -2.78, a price-to-earnings-growth ratio of 0.84 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $27.44.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm's revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is presently -13.50%.
Institutional Trading of DENTSPLY SIRONA
Large investors have recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth $25,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth $27,000. Parkside Financial Bank & Trust grew its holdings in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. Brooklyn Investment Group bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Institutional investors own 95.70% of the company's stock.
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.